Menu
Riseup-PPD
  • About
    • Action Structure
    • Action Members
    • Action Partners
  • Working Groups
    • Working Group 1
    • Working Group 2
    • Working Group 3
    • Working Group 4
    • Working Group 5
    • Working Group 6
      • Team
    • COVID-19 Taskforce
  • Activities
    • Status of Events
    • MC Meetings
    • Training Schools
    • Workshops
    • ITC conference Grants
    • Virtual Networking Tools
    • International Conference 2023
    • International Conference 2022
      • Programme
      • Speakers
  • Calls
  • Dissemination
    • Research Publications
    • Presentations
    • Publication Guidelines
    • Press
    • Newsletter
    • Flyer
  • Contact
  • About
    • Action Structure
    • Action Members
    • Action Partners
  • Working Groups
    • Working Group 1
    • Working Group 2
    • Working Group 3
    • Working Group 4
    • Working Group 5
    • Working Group 6
      • Team
    • COVID-19 Taskforce
  • Activities
    • Status of Events
    • MC Meetings
    • Training Schools
    • Workshops
    • ITC conference Grants
    • Virtual Networking Tools
    • International Conference 2023
    • International Conference 2022
      • Programme
      • Speakers
  • Calls
  • Dissemination
    • Research Publications
    • Presentations
    • Publication Guidelines
    • Press
    • Newsletter
    • Flyer
  • Contact

​WG2: ASSESSMENT APPROACHES AND METHODS IN PPD

Leader: Ilaria Lega (Italy)
Co-Leader: Alkistis Skalkidou (Sweden)

Previous Leader: Colin Martin (UK)
Previous Co-Leader: Helena Moreira (Portugal)

Objectives: Appraise, develop and define standard procedures to: i) assess women diagnosed with PPD (pre- and post-treatment); ii) collect genetic and epigenetic biomarkers; iii) assess the impact of PPD in the newborn-infant development (0-12 months); iv) assess interpersonal functioning (the mother-baby dyad and the father-mother-baby triad). 

Tasks: i) Develop an overview of the current assessment procedures for the main players in PPD and their interactions, in multiple domains: cognition,, emotion, personality, autonomy, psychopathology, quality of life and interpersonal functioning; ii) Propose assessment standards for each intervenient and dimension; iii) Provide researchers and practitioners with training courses in (neuro)psychological assessment tools for women with PPD, the dyad mother-baby and the triad father-mother-baby; iv) Provide researchers and practitioners with training courses in the assessment of neurocognitive development of newborn-infants; v) Provide researchers with training courses in biomarkers; vi) Develop scientific outputs to disseminate achieved standards for each assessment target. 

Milestones: WG Meetings; 2 TSs for health professionals (on PPD clinical diagnosis and assessment, and on infant’s neurodevelopment assessment); 2 STSMs in assessment methods; 2 Workshops (1 for primary care professionals and 1 for undergraduate students).

​Deliverables: Publications on current trans-disciplinary assessment procedures and tools in Peripartum Depression Disorder; Proposals for concrete guidelines or input to standards for the assessment of each intervenient and dimension.

WG Activities

WG2 Workshop on Jan. 24 2022 
Powered by Create your own unique website with customizable templates.